Cargando…

Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction

Background and Objectives: Tadalafil is expected to treat fetal growth restriction (FGR), a risk factor for stillbirth and neonatal morbidity. This study aimed to evaluate the fetal biometric growth pattern of fetuses with FGR treated with tadalafil by ultrasonographic assessment. Materials and Meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsuji, Makoto, Maki, Shintaro, Enomoto, Naosuke, Okamoto, Kota, Kitamura, Asa, Magawa, Shoichi, Takakura, Sho, Nii, Masafumi, Tanaka, Kayo, Yodoya, Noriko, Tanaka, Hiroaki, Sawada, Hirofumi, Kondo, Eiji, Hirayama, Masahiro, Ikeda, Tomoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223650/ https://www.ncbi.nlm.nih.gov/pubmed/37241131 http://dx.doi.org/10.3390/medicina59050900

Ejemplares similares

Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction
por: Maki, Shintaro, et al.
Publicado: (2020)

Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction
por: Tsuchiya, Kyoka, et al.
Publicado: (2020)

Maternal Blood Concentration of Tadalafil and Uterine Blood Flow in Pregnancy
por: Tanaka, Hiroaki, et al.
Publicado: (2019)

Evaluation of fetal acidemia during delivery using the conventional 5-tier classification and Rainbow systems
por: Magawa, Shoichi, et al.
Publicado: (2023)

Placental growth factor level is correlated with intrapartum fetal heart rate findings
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

Appropriate Method of Administering Vasopressors for Maternal Hypotension Associated with Combined Spinal Epidural Anesthesia in Elective Cesarean Section: Impact on Postnatal Respiratory Support for Newborns
por: Magawa, Shoichi, et al.
Publicado: (2022)

Accurate evaluation of the progress of delivery with transperineal ultrasound may improve vaginal delivery: a single-center retrospective study
por: Enomoto, Naosuke, et al.
Publicado: (2023)

Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions
por: Tachibana, Ryota, et al.
Publicado: (2019)

The Successful Use of Nitroglycerin for Uterine Hyperstimulation with Fetal Heart Rate Abnormality Caused by a Controlled-Release Dinoprostone Vaginal Delivery System (PROPESS): A Case Report
por: Takakura, Sho, et al.
Publicado: (2021)

Tadalafil Treatment of Mice with Fetal Growth Restriction and Preeclampsia Improves Placental mTOR Signaling
por: Tanaka, Kayo, et al.
Publicado: (2022)

Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial
por: Maki, Shintaro, et al.
Publicado: (2019)

Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring
por: Kawamura, Takuya, et al.
Publicado: (2021)

TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial
por: Umekawa, Takashi, et al.
Publicado: (2018)

Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report
por: Sakamoto, Mito, et al.
Publicado: (2016)

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

Relationship between Edinburg Postnatal Depression Scale (EPDS) Scores in the Early Postpartum Period and Related Stress Coping Characteristics
por: Magawa, Shoichi, et al.
Publicado: (2022)

Fetal heart rate variability is a biomarker of rapid but not progressive exacerbation of inflammation in preterm fetal sheep
por: Magawa, Shoichi, et al.
Publicado: (2022)

Fetal Growth Restriction: Comparison of Biometric Parameters
por: Marchand, Carolin, et al.
Publicado: (2022)

Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb)
por: Maki, Shintaro, et al.
Publicado: (2022)

Fetal biometric and Doppler measurements following abdominal radical trachelectomy in the second trimester of the pregnancy
por: Shima, Eiri, et al.
Publicado: (2022)

Prevention of fetal brain injury in category II tracings
por: Nakao, Masahiro, et al.
Publicado: (2023)

The World Health Organization Fetal Growth Charts: A Multinational Longitudinal Study of Ultrasound Biometric Measurements and Estimated Fetal Weight
por: Kiserud, Torvid, et al.
Publicado: (2017)

Correlation of Fetal Anterior Abdominal Wall Thickness and Other Standard Biometric Ultrasound Measurements to Predict Fetal Macrosomia in Gestational Diabetes
por: Bansal, Ashish, et al.
Publicado: (2022)

A comparative study on third trimester fetal biometric parameters with maternal age
por: Poojari, Yogitha, et al.
Publicado: (2023)

Preliminary analysis of in utero low-level arsenic exposure and fetal growth using biometric measurements extracted from fetal ultrasound reports
por: Davis, Matthew A, et al.
Publicado: (2015)

Correction: The World Health Organization Fetal Growth Charts: A Multinational Longitudinal Study of Ultrasound Biometric Measurements and Estimated Fetal Weight
por: Kiserud, Torvid, et al.
Publicado: (2017)

Correction: The World Health Organization Fetal Growth Charts: A Multinational Longitudinal Study of Ultrasound Biometric Measurements and Estimated Fetal Weight
por: Kiserud, Torvid, et al.
Publicado: (2021)

Swedish intrauterine growth reference ranges of biometric measurements of fetal head, abdomen and femur
por: Lindström, Linda, et al.
Publicado: (2020)

Household air pollution, ultrasound measurement, fetal biometric parameters and intrauterine growth restriction
por: Dutta, Anindita, et al.
Publicado: (2021)

Correction: Correction: The World Health Organization Fetal Growth Charts: A Multinational Longitudinal Study of Ultrasound Biometric Measurements and Estimated Fetal Weight
Publicado: (2017)

Fetal endocrinology
por: Kota, Sunil Kumar, et al.
Publicado: (2013)

Relationship between fetal biometric assessment by ultrasonography and neonatal lamb vitality, birth weight and growth
por: Vannucchi, Camila Infantosi, et al.
Publicado: (2019)

Longitudinal Associations Between Maternal Glucose Levels and Ultrasonographic Fetal Biometrics in a Shanghai Cohort
por: Zou, Jiao-jiao, et al.
Publicado: (2022)

Risk Factors for Cardiovascular Events among Pregnant Women with Cardiovascular Disease
por: Nii, Masafumi, et al.
Publicado: (2020)

Fetal Biometric Charts and Reference Equations for Pregnant Women Living in Port Said and Ismailia Governorates in Egypt
por: Hegab, Moustafa, et al.
Publicado: (2018)

Fetal biometric parameters: Reference charts for a non-selected risk population from Uberaba, Brazil
por: Peixoto, Alberto Borges, et al.
Publicado: (2017)

Author Correction: Swedish intrauterine growth reference ranges of biometric measurements of fetal head, abdomen and femur
por: Lindström, Linda, et al.
Publicado: (2021)

Does Vaginal Cuff Creation and Avoidance of a Uterine Manipulator Improve the Prognosis of Total Laparoscopic Radical Hysterectomy for Early Cervical Cancer? A Retrospective Multicenter Study
por: Kondo, Eiji, et al.
Publicado: (2022)

Dependency of magnetocardiographically determined fetal cardiac time intervals on gestational age, gender and postnatal biometrics in healthy pregnancies
por: van Leeuwen, Peter, et al.
Publicado: (2004)

Impact of prenatal maternal psychological distress on fetal biometric parameters in household air pollution-exposed Nigerian women
por: Deji-Abiodun, Oluwafunmilade, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ed7h9aq0v8s92raselq1nsdlr